Alberto Sanchez-Fueyo

Title: Alberto Sanchez-Fueyo: Innovator in Immune Modulation

Introduction

Alberto Sanchez-Fueyo is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of immunology, particularly in the development of innovative methods for modulating immune responses. With a total of two patents to his name, his work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Sanchez-Fueyo's latest patents focus on TIM-3 ligands and methods of modulating immune responses. The first patent relates to isolated polypeptides and nucleic acids encoding polypeptides that comprise a TIM-3 IgV domain and a TIM-3 intracellular domain. Importantly, these polypeptides do not include a TIM-3 mucin domain or a TIM-3 transmembrane domain. The invention also outlines methods for modulating immune responses in a subject by administering a therapeutically effective amount of an agent that modulates TIM-3 activity. These immune responses encompass immune tolerance, transplantation tolerance, Th1 responses, and Th2 responses.

Career Highlights

Throughout his career, Sanchez-Fueyo has worked with esteemed institutions such as The Brigham and Women's Hospital and Beth Israel Deaconess Medical Center. His research has contributed to advancements in understanding immune mechanisms and developing therapeutic strategies.

Collaborations

Sanchez-Fueyo has collaborated with notable colleagues in the field, including Vijay K Kuchroo and Terry Barton Strom. These collaborations have further enriched his research and innovation efforts.

Conclusion

Alberto Sanchez-Fueyo stands out as an influential inventor in the realm of immune modulation. His patents and collaborative efforts reflect his commitment to advancing medical science and improving patient outcomes.